α-Synuclein–Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
The trophic response of dopamine neurons to GDNF, mediated by the transcription factor Nurr1, protects them from α-synuclein–mediated toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Ungerstedt, U., & Arbuthnott, G. W. (1970) · Brain Research · doi:10.1016/0006-8993(70)90187-3 · Cited by 1,978
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N., & Heywood, P. (2003) · Nature Medicine · doi:10.1038/nm850 · Cited by 1,290
Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J., Chen, E.-Y., Palfi, S., Roitberg, B. Z., et al. (2000) · Science · doi:10.1126/science.290.5492.767 · Cited by 1,251
A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons
Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., Hannon, G., & Abeliovich, A. (2007) · Science · doi:10.1126/science.1140481 · Cited by 1,187
Dopamine Neuron Agenesis in Nurr1-Deficient Mice
Zetterström, R. H., Solomin, L., Jansson, L., Hoffer, B. J., Olson, L., & Perlmann, T. (1997) · Science · doi:10.1126/science.276.5310.248 · Cited by 1,092
Self-citationSirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease
Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K. E., Amore, A. M., Volk, C. B., Maxwell, M. M., Rochet, J.-C., McLean, P. J., et al. (2007) · Science · doi:10.1126/science.1143780 · Cited by 1,062
Lang, A. E., Gill, S., Patel, N. K., Lozano, A., Nutt, J. G., Penn, R., Brooks, D. J., Hotton, G., Moro, E., Heywood, P., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20737 · Cited by 983
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
Nutt, J. G., Burchiel, K. J., Comella, C. L., Jankovic, J., Lang, A. E., Laws, E. R., Lozano, A. M., Penn, R. D., Simpson, R. K., Stacy, M., et al. (2003) · Neurology · doi:10.1212/wnl.60.1.69 · Cited by 824
Saucedo-Cardenas, O., Quintana-Hau, J. D., Le, W.-D., Smidt, M. P., Cox, J. J., De Mayo, F., Burbach, J. P. H., & Conneely, O. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.4013 · Cited by 742
Repression of α-synuclein expression and toxicity by microRNA-7
Junn, E., Lee, K.-W., Jeong, B. S., Chan, T. W., Im, J.-Y., & Mouradian, M. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906277106 · Cited by 655 · cited 1×
“By contrast, concentrations of miR-7 (170 ± 15%) and miR-153 (180 ± 19%), regulators of a-synuclein (27, 28), were Fig.”
α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Kontopoulos, E., Parvin, J. D., & Feany, M. B. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl243 · Cited by 537
Is CREB a key to neuronal survival?
Walton, M. R., & Dragunow, M. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01500-3 · Cited by 520
Mutations in NR4A2 associated with familial Parkinson disease
Le, W.-D., Xu, P., Jankovic, J., Jiang, H., Appel, S. H., Smith, R. G., & Vassilatis, D. K. (2003) · Nature Genetics · doi:10.1038/ng1066 · Cited by 487
Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
Doxakis, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086827 · Cited by 454
Priorities in Parkinson's disease research
Meissner, W. G., Frasier, M., Gasser, T., Goetz, C. G., Lozano, A., Piccini, P., Obeso, J. A., Rascol, O., Schapira, A., Voon, V., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3430 · Cited by 436
Chu, Y., & Kordower, J. H. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.021 · Cited by 396
Chung, C. Y., Koprich, J. B., Siddiqi, H., & Isacson, O. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5427-08.2009 · Cited by 391
Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons
Kadkhodaei, B., Ito, T., Joodmardi, E., Mattsson, B., Rouillard, C., Carta, M., Muramatsu, S.-I., Sumi-Ichinose, C., Nomura, T., Metzger, D., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3910-09.2009 · Cited by 382
Self-citationBjörklund, A., Kirik, D., Rosenblad, C., Georgievska, B., Lundberg, C., & Mandel, R. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02915-2 · Cited by 346
Self-citationNuclear Localization of α-Synuclein and Its Interaction with Histones
Goers, J., Manning-Bog, A. B., McCormack, A. L., Millett, I. S., Doniach, S., Di Monte, D. A., Uversky, V. N., & Fink, A. L. (2003) · Biochemistry · doi:10.1021/bi0341152 · Cited by 337
Absolute requirement of GDNF for adult catecholaminergic neuron survival
Pascual, A., Hidalgo-Figueroa, M., Piruat, J. I., Pintado, C. O., Gómez-Díaz, R., & López-Barneo, J. (2008) · Nature Neuroscience · doi:10.1038/nn.2136 · Cited by 334
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons
Lundblad, M., Decressac, M., Mattsson, B., & Björklund, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200575109 · Cited by 292
Self-citationLocalized striatal delivery of GDNF as a treatment for Parkinson disease
Kirik, D., Georgievska, B., & Björklund, A. (2004) · Nature Neuroscience · doi:10.1038/nn1175 · Cited by 290
Self-citationDecressac, M., Mattsson, B., Lundblad, M., Weikop, P., & Björklund, A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.013 · Cited by 286
Self-citationα-Synuclein and dopamine at the crossroads of Parkinson's disease
Venda, L. L., Cragg, S. J., Buchman, V. L., & Wade-Martins, R. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.09.004 · Cited by 285
Tomac, A., Widenfalk, J., Lin, L. F., Kohno, T., Ebendal, T., Hoffer, B. J., & Olson, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8274 · Cited by 258
Glutamate Receptors on Dopamine Neurons Control the Persistence of Cocaine Seeking
Engblom, D., Bilbao, A., Sanchis-Segura, C., Dahan, L., Perreau-Lenz, S., Balland, B., Parkitna, J. R., Luján, R., Halbout, B., Mameli, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.010 · Cited by 241
Nurr1 in Parkinson's disease and related disorders
Chu, Y., Le, W., Kompoliti, K., Jankovic, J., Mufson, E. J., & Kordower, J. H. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20828 · Cited by 224
Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis
Ma, X., Kumar, M., Choudhury, S. N., Becker Buscaglia, L. E., Barker, J. R., Kanakamedala, K., Liu, M.-F., & Li, Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103735108 · Cited by 214
Kramer, E. R., Aron, L., Ramakers, G. M. J., Seitz, S., Zhuang, X., Beyer, K., Smidt, M. P., & Klein, R. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050039 · Cited by 209
MicroRNA-124 is a subventricular zone neuronal fate determinant
Akerblom, M., Sachdeva, R., Barde, I., Verp, S., Gentner, B., Trono, D., & Jakobsson, J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0558-12.2012 · Cited by 207
Maxwell, M. M., Tomkinson, E. M., Nobles, J., Wizeman, J. W., Amore, A. M., Quinti, L., Chopra, V., Hersch, S. M., & Kazantsev, A. G. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr326 · Cited by 207
Jiang, L., Liu, X., Chen, Z., Jin, Y., Heidbreder, C. E., Kolokythas, A., Wang, A., Dai, Y., & Zhou, X. (2010) · Biochemical Journal · doi:10.1042/bj20100859 · Cited by 205
Parkinson's disease and α‐synuclein expression
Devine, M. J., Gwinn, K., Singleton, A., & Hardy, J. (2011) · Movement Disorders · doi:10.1002/mds.23948 · Cited by 199
Yu, S., Li, X., Liu, G., Han, J., Zhang, C., Li, Y., Xu, S., Liu, C., Gao, Y., Yang, H., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.028 · Cited by 194
Neurotoxic in vivo models of Parkinson’s disease
Cannon, J. R., & Greenamyre, J. T. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)84002-6 · Cited by 191
Azeredo da Silveira, S., Schneider, B. L., Cifuentes-Diaz, C., Sage, D., Abbas-Terki, T., Iwatsubo, T., Unser, M., & Aebischer, P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn417 · Cited by 190
(1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02218.x · Cited by 186
Quesada, A., Lee, B. Y., & Micevych, P. E. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20609 · Cited by 185
GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease
Decressac, M., Ulusoy, A., Mattsson, B., Georgievska, B., Romero-Ramos, M., Kirik, D., & Bjorklund, A. (2011) · Brain · doi:10.1093/brain/awr149 · Cited by 178
Self-citationCrossroads in GDNF therapy for Parkinson's disease
Sherer, T. B., Fiske, B. K., Svendsen, C. N., Lang, A. E., & Langston, J. W. (2006) · Movement Disorders · doi:10.1002/mds.20861 · Cited by 172
Bartus, R. T., Herzog, C. D., Chu, Y., Wilson, A., Brown, L., Siffert, J., Johnson, E. M., Olanow, C. W., Mufson, E. J., & Kordower, J. H. (2011) · Movement Disorders · doi:10.1002/mds.23442 · Cited by 171
NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection
Volakakis, N., Kadkhodaei, B., Joodmardi, E., Wallis, K., Panman, L., Silvaggi, J., Spiegelman, B. M., & Perlmann, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007088107 · Cited by 167 · cited 8×
“This suggests that Nurr1 is a mediator of CREB-dependent neuroprotective responses that are activated by pathological stimuli or cellular stress.”
BackgroundInfluentialSelf-citationJin, H., Kanthasamy, A., Ghosh, A., Yang, Y., Anantharam, V., & Kanthasamy, A. G. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5634-10.2011 · Cited by 165
Jacobs, F. M. J., van Erp, S., van der Linden, A. J. A., von Oerthel, L., Burbach, J. P. H., & Smidt, M. P. (2009) · Development · doi:10.1242/dev.029769 · Cited by 158
Decressac, M., Mattsson, B., & Björklund, A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.02.012 · Cited by 158
Self-citationmiR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics
Bar, N., & Dikstein, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010859 · Cited by 145
Nuclear and neuritic distribution of serine-129 phosphorylated α-synuclein in transgenic mice
Schell, H., Hasegawa, T., Neumann, M., & Kahle, P. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.002 · Cited by 142
Lo Bianco, C., Déglon, N., Pralong, W., & Aebischer, P. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.008 · Cited by 129
Repairing the parkinsonian brain with neurotrophic factors
Aron, L., & Klein, R. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.11.001 · Cited by 127
Quesada, A., Romeo, H. E., & Micevych, P. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21358 · Cited by 118
Production methods for gene transfer vectors based on adeno-associated virus serotypes
Grimm, D. (2002) · Methods · doi:10.1016/s1046-2023(02)00219-0 · Cited by 117
Pitx3 Is a Critical Mediator of GDNF-Induced BDNF Expression in Nigrostriatal Dopaminergic Neurons
Peng, C., Aron, L., Klein, R., Li, M., Wurst, W., Prakash, N., & Le, W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0898-11.2011 · Cited by 111
RET Is Dispensable for Maintenance of Midbrain Dopaminergic Neurons in Adult Mice
Jain, S., Golden, J. P., Wozniak, D., Pehek, E., Johnson, E. M., & Milbrandt, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1876-06.2006 · Cited by 105
Biochemical Fractionation of Brain Tissue for Studies of Receptor Distribution and Trafficking
Hallett, P. J., Collins, T. L., Standaert, D. G., & Dunah, A. W. (2008) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0116s42 · Cited by 92
Wakamatsu, M., Ishii, A., Ukai, Y., Sakagami, J., Iwata, S., Ono, M., Matsumoto, K., Nakamura, A., Tada, N., Kobayashi, K., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21310 · Cited by 91
Type 2 Diabetes in Childhood: The American Perspective
Libman, I., & Arslanian, S. (2003) · Hormone Research in Paediatrics · doi:10.1159/000067828 · Cited by 74
Trophic factors therapy in Parkinson's disease
Ramaswamy, S., Soderstrom, K. E., & Kordower, J. H. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17514-3 · Cited by 72
Nurr1 Protein Is Required for N-Methyl-d-aspartic Acid (NMDA) Receptor-mediated Neuronal Survival
Barneda‐Zahonero, B., Servitja, J., Badiola, N., Miñano-Molina, A. J., Fadó, R., Saura, C. A., & Rodríguez-Álvarez, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.272427 · Cited by 69
Characterisation of a novel NR4A2 mutation in Parkinson's disease brain
Abou‐Sleiman, P. M., Healy, D. G., Muqit, M. M. K., Yang, Y.-N., van der Brug, M., Holton, J. L., Révész, T., Quinn, N. P., Bhatia, K. P., Diss, J. K. J., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.021 · Cited by 53
Lei, Z., Jiang, Y., Li, T., Zhu, J., & Shuilin, Z. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822830e5 · Cited by 47
Torres, E. M., Lane, E. L., Heuer, A., Smith, G. A., Murphy, E., & Dunnett, S. B. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.06.012 · Cited by 45
Chu, Y., Mickiewicz, A. L., & Kordower, J. H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.022 · Cited by 43
Zhang, Z., Li, X., Xie, W., Tuo, H., Hintermann, S., Jankovic, J. J., & Le, W. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712803581155 · Cited by 34
Cited by
Lei, Z., Tan, I. B., Das, K., Deng, N., Zouridis, H., Pattison, S., Chua, C., Feng, Z., Guan, Y. K., Ooi, C. H., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.010 · Cited by 458
Schapira, A. H. V., Olanow, C. W., Greenamyre, J. T., & Bezard, E. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61010-2 · Cited by 392
How to make a midbrain dopaminergic neuron
Arenas, E., Denham, M., & Villaescusa, J. C. (2015) · Development · doi:10.1242/dev.097394 · Cited by 308
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
Charvin, D., Medori, R., Hauser, R. A., & Rascol, O. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.136 · Cited by 287
Warren Olanow, C., Bartus, R. T., Baumann, T. L., Factor, S., Boulis, N., Stacy, M., Turner, D. A., Marks, W., Larson, P., Starr, P. A., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24436 · Cited by 287
Metadata
- Authors
- Decressac, M., Kadkhodaei, B., Mattsson, B., Laguna, A., Perlmann, T., & Björklund, A.
- Venue
- Science Translational Medicine
- Published
- 2012-12-05
- Volume
- 4
- Issue
- 163
- Pages
- 163ra156-163ra156
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2103623402
- Cited by
- 290
- References
- 67
- FWCI
- 7.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.